NCT00843089

Brief Summary

Despite immediate symptomatic success after coronary bypass surgery in patients with coronary artery disease, this effect is not sustained over time since risk factors for coronary artery disease are still in place. The role of secondary prevention becomes increasingly important as it can potentially decrease or eliminate the need for another intervention in these high risk subjects. This project seeks to evaluate the effect of emphasizing secondary prevention measures in this patient population during hospital admission and through six months post-discharge.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
115

participants targeted

Target at P25-P50 for not_applicable coronary-artery-disease

Timeline
Completed

Started Jan 2009

Typical duration for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 12, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 13, 2009

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
Last Updated

July 1, 2014

Status Verified

June 1, 2014

Enrollment Period

4.4 years

First QC Date

February 12, 2009

Last Update Submit

June 27, 2014

Conditions

Coronary Artery Disease

Keywords

coronary artery diseaseCABG

Outcome Measures

Primary Outcomes (1)

  • compliance with medications and lifestyle changes

    Month 1, 3, 6 and 1 year

Study Arms (2)

1

NO INTERVENTION

Standard care

2

EXPERIMENTAL

Educational session with pharmacist, nutritionist, and cardiac rehabilitation nurse

Other: Education

Interventions

EducationOTHER

Educational session with pharmacist, nutritionist, and cardiac rehabilitation nurse

2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects over the age of 18 who will undergo a CABG procedure and who have given written informed consent

You may not qualify if:

  • Subjects under the age of 18 or who are unable to give consent on their own behald

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

Location

MeSH Terms

Conditions

Coronary Artery Disease

Interventions

Educational Status

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Study Officials

  • Jeffrey Kramer, MD

    University of Kansas Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
CTS SURGEON

Study Record Dates

First Submitted

February 12, 2009

First Posted

February 13, 2009

Study Start

January 1, 2009

Primary Completion

June 1, 2013

Study Completion

June 1, 2013

Last Updated

July 1, 2014

Record last verified: 2014-06

Locations

US(1)